- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/02 - Linear peptides containing at least one abnormal peptide link
Patent holdings for IPC class C07K 7/02
Total number of patents in this class: 699
10-year publication summary
|
33
|
27
|
55
|
57
|
42
|
49
|
47
|
38
|
37
|
28
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1144 |
76 |
| Protagonist Therapeutics, Inc. | 147 |
23 |
| Centre National de La Recherche Scientifique | 10708 |
11 |
| SeaGen Inc | 585 |
11 |
| University of South Florida | 1851 |
8 |
| L.e.a.f. Holdings Group LLC | 116 |
8 |
| Shenzhen HighTide Biopharmaceutical, Ltd. | 59 |
8 |
| The Regents of the University of California | 20296 |
7 |
| Pfizer Inc. | 3400 |
7 |
| Mersana Therapeutics, Inc. | 101 |
7 |
| Provincial Health Services Authority | 189 |
7 |
| Novartis AG | 10534 |
6 |
| Wisconsin Alumni Research Foundation | 3897 |
6 |
| Regeneron Pharmaceuticals, Inc. | 4448 |
6 |
| The University of British Columbia | 1534 |
6 |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | 56 |
6 |
| Bicyclerd Limited | 146 |
6 |
| Genentech, Inc. | 4005 |
5 |
| Takeda Pharmaceutical Company Limited | 2713 |
5 |
| Deutsches Krebsforschungszentrum | 413 |
5 |
| Other owners | 475 |